FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000524003: MOVED TO association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001152012 MOVED TO association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001153019 MOVED TO association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


22445 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
MOVED TO association reference set Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
[X]Agents primarily affecting the gastrointestinal system causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Agents primarily affecting water-balance and mineral and uric acid metabolism causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Air and space transport accidents Extension Namespace {1000000} (namespace concept)
[X]Airway disease due to other specific organic dusts Extension Namespace {1000000} (namespace concept)
[X]Alcohol deterrents causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Allergic contact dermatitis due to other agents Extension Namespace {1000000} (namespace concept)
[X]Allergic contact dermatitis due to other chemical products Extension Namespace {1000000} (namespace concept)
[X]Alpha-adrenoreceptor antagonists causing adverse effects in therapeutic use, not elsewhere classified Extension Namespace {1000000} (namespace concept)
[X]Amebiasis, unspecified Extension Namespace {1000000} (namespace concept)
[X]Amebic infection of other sites Extension Namespace {1000000} (namespace concept)
[X]Aminoglycosides causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Amputation of limb(s) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure Extension Namespace {1000000} (namespace concept)
[X]Analeptics causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Androgens and anabolic congeners causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Anemia (nonmegaloblastic) associated with other specified nutritional deficiencies Extension Namespace {1000000} (namespace concept)
[X]Anemia in other chronic diseases classified elsewhere Extension Namespace {1000000} (namespace concept)
[X]Anesthesiology devices associated with adverse incidents Extension Namespace {1000000} (namespace concept)
[X]Anesthesiology devices associated with adverse incidents, diagnostic and monitoring devices Extension Namespace {1000000} (namespace concept)
[X]Anesthesiology devices associated with adverse incidents, miscellaneous devices, not elsewhere classified Extension Namespace {1000000} (namespace concept)
[X]Anesthesiology devices associated with adverse incidents, prosthetic and other implants, materials and accessory devices Extension Namespace {1000000} (namespace concept)
[X]Anesthesiology devices associated with adverse incidents, surgical instruments, materials and devices (including sutures) Extension Namespace {1000000} (namespace concept)
[X]Anesthesiology devices associated with adverse incidents, therapeutic (nonsurgical) and rehabilitative devices Extension Namespace {1000000} (namespace concept)
[X]Anesthetics and therapeutic gases causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Aneurysm of aorta in diseases classified elsewhere Extension Namespace {1000000} (namespace concept)
[X]Aneurysm of other specified arteries Extension Namespace {1000000} (namespace concept)
[X]Angiotensin II receptor antagonists causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Angiotensin-converting-enzyme inhibitors causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Animal-rider or occupant of animal-drawn vehicle injured in transport accident Extension Namespace {1000000} (namespace concept)
[X]Anogenital herpes viral infection, unspecified Extension Namespace {1000000} (namespace concept)
[X]Anomalies of pupillary function in diseases classified elsewhere Extension Namespace {1000000} (namespace concept)
[X]Antenatal screening for fetal growth retardation using ultrasonics and other physical methods Extension Namespace {1000000} (namespace concept)
[X]Antenatal screening for malformations using ultrasonics and other physical methods Extension Namespace {1000000} (namespace concept)
[X]Anthrax, unspecified Extension Namespace {1000000} (namespace concept)
[X]Anti-common-cold drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antiallergic and antiemetic drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antiasthmatics causing adverse effects in therapeutic use, not elsewhere classified Extension Namespace {1000000} (namespace concept)
[X]Anticholinesterase agents causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Anticoagulant antagonists, vitamin K and other coagulants causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Anticoagulants causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antidiarrheal drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antidotes and chelating agents causing adverse effects in therapeutic use, not elsewhere classified Extension Namespace {1000000} (namespace concept)
[X]Antiepileptics and antiparkinsonism drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antigonadotrophins, antiestrogens, antiandrogens causing adverse effects in therapeutic use, not elsewhere classified Extension Namespace {1000000} (namespace concept)
[X]Antihelminthics causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antihyperlipidemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antimalarials and drugs acting on other blood protozoa causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antimycobacterial drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antineoplastic antimetabolites causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antineoplastic natural products causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antiparkinsonism drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antipruritics causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antirheumatics causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antispasticity drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antithrombotic drugs [platelet-aggregation inhibitors] causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antithyroid drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antitussives causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antivaricose drugs, including sclerosing agents, causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Antiviral drugs causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Anxiety disorder, unspecified Extension Namespace {1000000} (namespace concept)
[X]Aortic aneurysm of unspecified site, nonruptured Extension Namespace {1000000} (namespace concept)
[X]Aortic aneurysm of unspecified site, ruptured Extension Namespace {1000000} (namespace concept)
[X]Aortic valve disorders in diseases classified elsewhere Extension Namespace {1000000} (namespace concept)
[X]Aortitis in diseases classified elsewhere Extension Namespace {1000000} (namespace concept)
[X]Aplastic and other anemias Extension Namespace {1000000} (namespace concept)
[X]Apocrine sweat disorder, unspecified Extension Namespace {1000000} (namespace concept)
[X]Apocrine sweat disorder, unspecified Extension Namespace {1000000} (namespace concept)
[X]Appetite depressants [anorectics] causing adverse effects in therapeutic use Extension Namespace {1000000} (namespace concept)
[X]Arenaviral hemorrhagic fever, unspecified Extension Namespace {1000000} (namespace concept)
[X]Arthritis and polyarthritis due to other specified bacterial agents Extension Namespace {1000000} (namespace concept)
[X]Arthritis in other infectious and parasitic diseases classified elsewhere Extension Namespace {1000000} (namespace concept)
[X]Arthropathies in other endocrine, nutritional and metabolic disorders Extension Namespace {1000000} (namespace concept)
[X]Arthropathies in other specified diseases classified elsewhere Extension Namespace {1000000} (namespace concept)
[X]Arthropathy in hypersensitivity reactions classified elsewhere Extension Namespace {1000000} (namespace concept)
[X]Arthropathy in neoplastic disease classified elsewhere Extension Namespace {1000000} (namespace concept)
[X]Arthropathy in other blood disorders classified elsewhere Extension Namespace {1000000} (namespace concept)
[X]Arthropod-borne viral encephalitis, unspecified Extension Namespace {1000000} (namespace concept)
[X]Arthropod-borne viral fevers and viral hemorrhagic fevers Extension Namespace {1000000} (namespace concept)
[X]Arthrosis Extension Namespace {1000000} (namespace concept)
[X]Ascariasis with other complications Extension Namespace {1000000} (namespace concept)
[X]Ascariasis, unspecified Extension Namespace {1000000} (namespace concept)
[X]Ascariasis, unspecified Extension Namespace {1000000} (namespace concept)
[X]Aspergillosis, unspecified Extension Namespace {1000000} (namespace concept)
[X]Aspergillosis, unspecified Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object, occurrence at home Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object, occurrence at industrial and construction area Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object, occurrence at other specified place Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object, occurrence at school, other institution and public administrative area Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object, occurrence at sports and athletics area Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object, occurrence at trade and service area Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object, occurrence at unspecified place Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object, occurrence in residential institution Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object, occurrence on farm Extension Namespace {1000000} (namespace concept)
[X]Assault by blunt object, occurrence on street and highway Extension Namespace {1000000} (namespace concept)
[X]Assault by bodily force Extension Namespace {1000000} (namespace concept)
[X]Assault by bodily force, occurrence at home Extension Namespace {1000000} (namespace concept)
[X]Assault by bodily force, occurrence at industrial and construction area Extension Namespace {1000000} (namespace concept)
[X]Assault by bodily force, occurrence at other specified place Extension Namespace {1000000} (namespace concept)
[X]Assault by bodily force, occurrence at school, other institution and public administrative area Extension Namespace {1000000} (namespace concept)
[X]Assault by bodily force, occurrence at sports and athletics area Extension Namespace {1000000} (namespace concept)

Start Previous Page 159 of 225 Next End


Reference Sets

Reference set descriptor

Back to Start